🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 13 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/08/2001 | 6,83 | 6,95 | 6,73 | 6,85 | +1,11% | 3,30% | 230.400 |
| 29/08/2001 | 6,68 | 6,78 | 6,63 | 6,78 | +0,82% | 2,25% | 68.600 |
| 28/08/2001 | 6,75 | 6,75 | 6,68 | 6,72 | -0,22% | 1,11% | 89.600 |
| 27/08/2001 | 6,75 | 6,88 | 6,68 | 6,74 | -0,44% | 2,89% | 156.200 |
| 24/08/2001 | 6,85 | 6,88 | 6,75 | 6,77 | -0,66% | 1,82% | 566.000 |
| 23/08/2001 | 6,75 | 6,89 | 6,65 | 6,81 | +0,96% | 3,63% | 599.000 |
| 22/08/2001 | 6,93 | 6,93 | 6,63 | 6,75 | -0,88% | 4,26% | 425.200 |
| 21/08/2001 | 6,73 | 6,95 | 6,73 | 6,81 | +0,07% | 3,35% | 90.200 |
| 20/08/2001 | 6,87 | 6,95 | 6,63 | 6,80 | -2,02% | 4,59% | 638.400 |
| 17/08/2001 | 6,85 | 7,00 | 6,83 | 6,94 | +0,58% | 2,55% | 217.600 |
| 16/08/2001 | 6,93 | 7,00 | 6,81 | 6,90 | +0,66% | 2,82% | 404.000 |
| 15/08/2001 | 6,74 | 6,93 | 6,73 | 6,86 | +2,08% | 2,97% | 589.400 |
| 14/08/2001 | 6,77 | 6,85 | 6,69 | 6,72 | -1,61% | 2,44% | 2.224.800 |
| 13/08/2001 | 7,10 | 7,40 | 6,68 | 6,83 | -2,50% | 10,21% | 3.662.200 |
| 10/08/2001 | 6,77 | 7,12 | 6,40 | 7,00 | +58,91% | 10,64% | 7.829.200 |
| 09/08/2001 | 4,41 | 4,41 | 4,41 | 4,41 | +0,00% | 0,00% | 0 |
| 08/08/2001 | 6,03 | 6,23 | 4,39 | 4,41 | -28,66% | 30,43% | 1.858.000 |
| 07/08/2001 | 6,31 | 6,31 | 6,03 | 6,18 | -0,08% | 4,44% | 287.000 |
| 06/08/2001 | 6,13 | 6,30 | 5,78 | 6,18 | +0,49% | 8,56% | 211.600 |
| 03/08/2001 | 6,08 | 6,17 | 5,85 | 6,15 | +1,23% | 5,27% | 256.200 |
| 02/08/2001 | 6,15 | 6,15 | 5,95 | 6,08 | +0,00% | 3,33% | 581.800 |
| 01/08/2001 | 6,20 | 6,20 | 5,90 | 6,08 | -0,49% | 4,76% | 203.600 |
| 31/07/2001 | 6,08 | 6,16 | 6,00 | 6,11 | -0,25% | 2,63% | 267.400 |
| 30/07/2001 | 6,00 | 6,13 | 5,89 | 6,12 | +2,43% | 4,00% | 251.200 |
| 27/07/2001 | 5,86 | 6,09 | 5,86 | 5,98 | +2,22% | 3,93% | 534.600 |
| 26/07/2001 | 6,10 | 6,17 | 5,80 | 5,85 | -1,76% | 6,07% | 423.200 |
| 25/07/2001 | 6,10 | 6,10 | 5,88 | 5,95 | -0,67% | 3,61% | 200.200 |
| 24/07/2001 | 6,12 | 6,14 | 5,91 | 5,99 | -0,25% | 3,76% | 108.200 |
| 23/07/2001 | 6,03 | 6,25 | 5,96 | 6,01 | -2,75% | 4,89% | 124.600 |
| 20/07/2001 | 6,00 | 6,21 | 6,00 | 6,18 | +1,98% | 3,50% | 125.600 |